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Abstract: 
Self-system therapy (SST) is a new therapy based on regulatory focus theory (E. T. Higgins, 
1997) for depressed individuals unable to pursue promotion goals effectively. The authors 
conducted a randomized trial comparing SST with cognitive therapy (CT) in a sample of 45 
patients with a range of depressive symptoms to test 2 hypotheses: that SST would be more 
efficacious for depressed individuals characterized by inadequate socialization toward pursuing 
promotion goals and that SST would lead to greater reduction in dysphoric responses to priming 
of promotion goals. There was no overall difference in efficacy between treatments, but patients 
whose socialization history lacked an emphasis on promotion goals showed significantly greater 
improvement with SST. In addition, SST patients showed a greater reduction in dysphoric 
responses to promotion goal priming than did CT patients. The results illustrate the value of a 
theory-based translational approach to treatment design and selection. 
Keywords: depression | cognitive therapy | regulatory focus theory | self-system therapy | 
translational research | self-regulatory dysfunction 
Article: 
Despite the availability of efficacious treatments for depression, a priori identification of optimal 
treatment for individual patients remains elusive ( Craighead, Hart, Craighead, & Ilardi, 2002; 
Norcross, Beutler, & Caldwell, 2002). Matching treatments to the characteristics of individual 
patients requires theory-based procedures for assessment and selection ( Hollon, Thase, & 
Markowitz, 2002; Strauman & Merrill, 2004). Translational approaches to treatment 
development and matching could provide additional options for treatment as well as reliable and 
valid bases for treatment selection ( National Institute of Mental Health, 2000). 
In this article, we report a randomized trial of a new therapy for depression, self-system therapy 
(SST; Vieth et al., 2003). SST is based on a model of depression as a disorder of motivation and 
goal pursuit resulting from chronic failure to attain certain kinds of personal goals. The trial 
examined whether SST would be more effective than cognitive therapy (CT; Beck, Rush, Shaw, 
& Emery, 1979) for the treatment of depressed individuals whose socialization history lacked an 
emphasis on promotion goals and who therefore could be vulnerable to depression because they 
were less able to pursue such goals effectively. 
Self-Regulation, Goal Pursuit, and Depression 
Research in personality and social psychology has identified potential mechanisms by which 
problems in self-regulation, defined as the ongoing process of evaluating one's progress toward 
important personal goals ( Carver, 2004), could contribute to the onset and maintenance of 
depression. Regulatory focus theory ( Higgins, 1997) is a model of self-regulation that proposes 
two kinds of goals, each associated with specific motivational states and strategies for goal 
pursuit. Promotion goals involve advancement, growth, and achievement; pursuing promotion 
goals means making good things happen, which is associated with either joyful or dysphoric 
mood depending on one's perceived progress. Prevention goals involve security, safety, and 
responsibility; pursuing prevention goals involves keeping bad things from happening, which is 
associated with either quiescent or anxious affect also depending on one's perceived progress. 
Individual differences in regulatory focus are conceptually and empirically distinct from 
individual differences in constructs such as mastery, self-esteem, or self-efficacy ( Förster, Grant, 
Idson, & Higgins, 2001). 
Regulatory focus theory stipulates that individuals whose socialization histories did not include a 
consistent emphasis on promotion will have difficulty attaining promotion goals during 
adolescence and adulthood ( Higgins, 1989; Higgins, Roney, Crowe, & Hymes, 1994). Such 
individuals would be unlikely to construe social interactions as opportunities to pursue 
promotion goals ( Higgins, Shah, & Friedman, 1997) and, as a result, would have fewer 
opportunities to experience the positive motivational and affective states associated with making 
progress toward a promotion goal ( Förster et al., 2001). Drawing on studies indicating that 
inability to attain promotion goals is predictive of dysphoric mood and depressive symptoms 
(e.g., Scott & O'Hara, 1993). Strauman (2002) proposed a self-regulation model of depression, 
postulating that individuals who are unable to pursue promotion goals effectively are at risk for 
mood disorders via a final common pathway ( Akiskal & McKinney, 1973) of dysphoric affect, 
decreased incentive motivation, and negative self-evaluation because of their chronic inability to 
make good things happen via progress toward their promotion goals. 
Depression results from and maintains disruption of the psychological and biological 
mechanisms of incentive motivation (e.g., Dickson & MacLeod, 2004; Sutton & Davidson, 
1997; Tomarken & Keener, 1998; Watson, Wiese, Vaidya, & Tellegen, 1999), and dysfunction 
of self-regulation is a risk factor for depression (e.g., Karoly, 1999; Kasch, Rottenberg, Arnow, 
& Gotlib, 2002; Lewinsohn, Allen, Seeley, & Gotlib, 1999). Recent evidence suggests a role for 
individual differences in orientation to promotion goals in vulnerability to depression. Using 
functional MRI, Merrill, Dolcos, Cabeza, and Strauman (2006) found that individuals whose 
self-reported socialization history lacked an emphasis on pursuing promotion goals manifested 
significantly weaker left prefrontal cortical activation when their promotion goals were activated 
than did individuals who reported consistent socialization for promotion goal pursuit. In turn, 
individual differences in left prefrontal cortical activation have been associated with both 
dispositional positive affectivity and vulnerability to depression ( Sutton & Davidson, 1997). 
Consistent with this model, Merrill, McLean, Dolcos, Cabeza, and Strauman (2006) observed 
that depressed patients manifested significantly weaker left prefrontal cortical activation after 
priming of their own promotion goals than did matched nondepressed controls. 
Researchers have begun to examine the impact of treatment for depression on psychological 
mechanisms of goal pursuit. Strauman et al. (2001) found that three empirically supported 
treatments—Beck's cognitive therapy (CT; A. T. Beck, Rush, Shaw, & Emery, 1979; J. S. Beck, 
1995), interpersonal psychotherapy ( Klerman, Weissman, Rounsaville, & Chevron, 1984), and 
pharmacotherapy with selective serotonin reuptake inhibitors—were less effective for depressed 
individuals with chronic self-perceived failure in promotion goal pursuit than for other patients. 
If those patients were vulnerable to depression because of inadequate socialization toward 
pursuing promotion goals, then interventions to enhance promotion goal pursuit might help them 
recover more completely. 
Self-System Therapy 
SST is a new therapy designed for depressed individuals unable to pursue promotion goals 
effectively (see Vieth et al., 2003, for an extended presentation of the rationale, structure, and 
interventions of SST). SST incorporates techniques from a number of empirically supported 
psychotherapies (cf. Beutler, Clarkin, & Bongar, 2000), including CT, interpersonal 
psychotherapy, and behavioral activation therapy ( Jacobson, Martell, & Dimidjian, 2001). 
However, SST was designed to translate the principles of regulatory focus theory into an 
intervention for examining and modifying the individual's goals and strategies for pursuing them 
( Avants, Margolin, & Singer, 1994; Moretti, Higgins, & Feldman, 1990). SST can be 
summarized in four questions: What are your promotion and prevention goals? What are you 
doing to try to attain them? What is keeping you from making progress? What can you do 
differently? SST was designed so that within an overall emphasis on self-regulation, specific 
interventions from other therapies could be incorporated easily, allowing the patient and therapist 
to bring a broad range of techniques to bear on the patient's difficulties in goal pursuit. For 
example, SST emphasizes the use of behavioral activation, as do behavioral activation therapy 
and other therapies. However, in SST, behavioral activation is used in the service of enhancing 
promotion goal pursuit—that is, “What can you do today that would help you make progress 
toward that goal?” To the extent that SST is differentially efficacious for depressed individuals 
with problems in self-regulation, such efficacy would derive from its overall emphasis rather 
than from any specific techniques or interventions. 
We conducted a randomized trial to determine whether SST would be more efficacious than CT 
for depressed patients with a poor promotion socialization history, who according to regulatory 
focus theory would have difficulty pursuing promotion goals. CT was used as a comparison 
treatment because of its extensive support, the availability of trained CT therapists at our clinic, 
and the possibility of replicating findings ( Strauman et al., 2001) that CT and other efficacious 
treatments were not optimal for depressed patients with poor promotion goal pursuit. This first 
trial of SST included patients with a range of depressive symptoms, and treatment length was 
unconstrained. We tested two hypotheses: (a) that SST would be more efficacious than CT for 
depressed individuals characterized by inadequate socialization to pursue promotion goals (i.e., 
differential efficacy) and (b) that SST would lead to greater decrease in dysphoric responses to 
priming of promotion goals (i.e., differential mechanism of action) than CT. 
Method 
Participants 
Patients were recruited from 1999 to 2000 via announcements on local television news 
broadcasts and in newspapers, intake at a university psychiatric clinic or women's health clinic, 
or referral from a university counseling center. The university psychiatric clinic served as the site 
for the study. A total of 110 individuals made an initial inquiry about the study. 
The primary eligibility criteria were meeting Diagnostic and Statistical Manual of Mental 
Disorders (4th ed., or DSM–IV; American Psychiatric Association, 1994) criteria for major 
depressive disorder or dysthymic disorder, as well as scoring at least 16 on the Beck Depression 
Inventory (BDI; Beck, Ward, Mendelson, Mock, & Erbaugh, 1961) and on the 17-item version 
of the Hamilton Rating Scale for Depression (HRSD; Hamilton, 1960; Williams, 1988) at intake. 
Recruitment difficulties led us to include 6 individuals who missed meeting criteria for major 
depressive disorder or dysthymic disorder by a single item because their BDI and HRSD scores 
were above threshold. Individuals with a history of mania or psychosis, significant antisocial or 
borderline symptomatology, or current substance abuse were not eligible. Participants could not 
be receiving other treatments for depression concurrently, including individual or group 
psychotherapy, antidepressant medication, or putative herbal remedies; anxiolytic or sleep 
medications such as benzodiazepines were permitted. We also excluded individuals with health 
conditions that required medications (e.g., steroids) that could exacerbate depression. A total of 
65 of the 110 individuals screened were excluded by these criteria. 
The remaining 45 individuals were randomized after completing pretreatment measures; 39 (SST 
= 21, CT = 18) attended at least 12 sessions of psychotherapy and were classified as completers 
for purposes of data analysis, whereas 6 (SST = 3, CT = 3) did not and were classified as 
dropouts. Reasons for dropping out were an out-of-state move ( n = 1), diagnosis of a serious 
illness in a family member ( n = 1), and increased work demands or change of schedule ( n = 3). 
The remaining noncompleter did not respond to numerous attempts at contact. Follow-up data 
were obtained for 4 of the 6 noncompleters; for the other 2 noncompleters, pretreatment data 
were used in the intent-to-treat analyses. Figure 1 summarizes the flow of prospective patients 
through the study. There were no statistically significant differences between completers and 
noncompleters on any measured patient characteristic (all ps > .15).  
 
 
Figure 1. Flow diagram for patients through the posttreatment assessment, including attrition 
Procedure 
Screening 
Individuals were informed about the study, which had been approved by the University of 
Wisconsin–Madison Medical Center Institutional Review Board, and were screened for 
depressed mood, history of mania, current substance use, and current mental health treatment. 
Those not excluded were given questionnaires to complete. Of the 110 individuals who made an 
inquiry about the study, 60 were given the questionnaire packet. From among the 55 who 
completed and returned the questionnaires, 50 scored above threshold on the BDI and were 
scheduled for an intake appointment approximately 1 week later. All individuals deemed 
ineligible were given information about treatment alternatives in the local community. 
At intake, informed consent was obtained, the Structured Clinical Interview for the DSM–
IV Axis I Disorders (SCID; First, Gibbon, Spitzer, & Williams, 1995) and a goal interview (see 
below) were administered, and the intake clinician completed an HRSD. Eligible patients were 
scheduled for an additional visit before the start of treatment, at which an assessment of affective 
responses to promotion goal priming and the Wisconsin Personality Disorders Inventory–IV ( 
Klein et al., 1993; Smith, Klein, & Benjamin, 2003) were administered. Upon completion of all 
pretreatment measures, each participant was paid $50. Eligible patients were randomized by a 
research assistant via a random-numbers table. As explained earlier, of the 39 completers, 21 
received SST and 18 received CT. This sample size provided 72% statistical power to detect a 
medium effect size (Cohen's d = 0.5) in a hierarchical multiple regression analysis ( Cohen, 
1988). 
Course of treatment 
Treatment was provided without charge, and length of treatment was unconstrained. 
Approximately every fourth session was videotaped or audiotaped. For the first six sessions, 
therapists and patients met weekly; subsequent sessions were conducted at least once every other 
week (average: for SST, once every 8.1 days; for CT, once every 7.2 days). Treatment was ended 
when the therapist indicated the final task of the treatment (discussion of relapse prevention for 
both CT and SST) was completed. For 3 of the 39 patients designated as completers (2 SST, 1 
CT), treatment was terminated by the patient before all treatment tasks had been completed. 
Approximately 2 weeks after treatment ended, participants repeated a subset of the measures 
taken at pretreatment, including the BDI and an HRSD administered by research staff blind to 
treatment condition, and were paid $50. 
Therapists/intake clinicians 
Nine therapists (two faculty clinical psychologists, four clinical psychology postdoctoral fellows, 
and three clinical psychology predoctoral interns) provided treatment. Seven therapists saw 
patients in both treatment conditions, one in CT alone, and one in SST alone. The therapists' 
average age was 33.8 years ( SD = 6.6), and their average years of therapy experience was 7.0 
( SD = 4.1; range = 4–15). The predoctoral- and postdoctoral-level therapists all had undergone 
prior training in CT, had a minimum of 3 years of CT experience, and received weekly 
individual supervision on their CT cases from one of the faculty-level therapists. In addition, 
study therapists attended a formal weekly CT didactic seminar conducted by Timothy J. 
Strauman, who is a Fellow of the Academy of Cognitive Therapy. All study therapists received 
training in SST before as well as during the study. Therapists were required to study the SST 
manual ( Strauman et al., 2001) and to attend weekly group meetings for discussion, case 
presentations, and videotape or audiotape review. Study therapists also administered SCID 
interviews at intake before randomization, and posttreatment assessments were conducted by 
study personnel who were blind to treatment condition. 
Measures 
Background questionnaire (pretreatment) 
Participants completed a background questionnaire designed for the study. In addition to 
standard demographic questions, the measure inquired about the respondent's history of mental 
health diagnoses and treatment. 
SCID–Patient Edition, Version 2.0 (pretreatment) 
The SCID ( First et al., 1995) is a widely used semistructured interview for diagnosis of Axis I 
disorders as described in the fourth edition of the DSM ( American Psychiatric Association, 
1994). Intake clinicians completed all nonoptional modules except for Module G (Somatoform 
Disorders), which was completed if time permitted. 
Regulatory Focus Questionnaire (RFQ; pretreatment) 
The RFQ ( Higgins et al., 2001) is a 22-item self-report measure of individual differences in 
orientation to promotion and prevention goals consisting of four subscales: Promotion History (5 
items assessing the extent to which the respondent was socialized as a child to construe situations 
in terms of promotion goals, e.g. having parents who celebrated the respondent's 
accomplishments), Promotion Pride (6 items assessing the extent to which the respondent feels a 
sense of pride and well-being from the pursuit of promotion goals, e.g., becoming more 
motivated by accomplishments), and corresponding Prevention History (5 items assessing the 
extent to which the respondent was socialized as a child to construe situations in terms of 
prevention goals, e.g., having parents who pointed out possible dangers) and Prevention Pride (6 
items assessing the extent to which the respondent feels a sense of pride and well-being from the 
pursuit of prevention goals, e.g., feeling good about following rules) subscales. Merrill, Dolcos, 
et al. (2006) reported internal consistency values (coefficient alpha) of .78, .74, .79, and .81 for 
the Promotion History, Prevention History, Promotion Pride, and Prevention Pride subscales, 
respectively, and observed that the two History subscales were uncorrelated ( r = .08), whereas 
the Pride subscales were moderately correlated ( r = .41). Furthermore, the History subscales 
were not significantly correlated with depressive symptoms in the Merrill, Dolcos, et al. (2006) 
study (both r < .10), whereas the Pride subscales were ( r = .42 for Promotion Pride and .38 for 
Prevention Pride). Thus, we anticipated that the History subscales were more likely to predict 
treatment outcome. 
Goal interview (pretreatment) 
To assess patients' promotion goals, we administered an interview version of the Selves 
Questionnaire (SQ; Higgins, Bond, Klein, & Strauman, 1986) in which patients were asked 
about their ideals (hopes and aspirations), which constitute important promotion goals ( Higgins 
et al., 1997). The SQ, a free-response measure on which participants are asked to describe their 
actual self, their ideal self, and their “ought” self, was administered individually. In the 
interview, the patient was asked about his or her own beliefs as well as her or his perceptions of 
what significant others (e.g., a spouse or parent) would say about them. Responses to the ideal- 
and ought-self questions in the interview were most often trait attributes such as “successful,” 
“loving,” “conscientious,” “hardworking,” “kind,” or “independent.” Stimuli for the goal-
priming task (see below) were selected from each patient's set of responses to the interview. 
Assessment of affective responses to promotion goal priming (pretreatment and 
posttreatment) 
We assessed affective responses to priming of promotion goals using a previously developed 
childhood memory task ( Strauman, 1992). Participants were presented with a series of words 
and were instructed to use each word to verbalize the first memory that came to mind. Unknown 
to participants, the word list had been created in part on the basis of their responses to the goal 
interview and included two types of goals. Five promotion goals were selected from among a 
participant's ideal-self responses that were unique to the ideal domain. Five yoked-control cues 
were selected from the promotion goals of other participants (and so were positively valenced as 
well). These cues were not semantically related to any goal generated by the participant in the 
goal interview. The yoked-control cues tested the alternative hypothesis that the words 
themselves, rather than their status as goals, influenced participants' responses. The same word 
list was used for the pretreatment and posttreatment assessment. 
Each participant was told that she or he would be presented with words to help her or him 
remember experiences from childhood. For each word, the participant was to describe aloud the 
first memory that came to mind. Participants had 30 s to retrieve a memory, after which the trial 
was considered a memory failure and they were given the next word. Two practice trials using 
the words pleasant and content were conducted. Words were presented in random order, and 
verbalized memories were audiotaped and later transcribed. Memories of recent events were not 
scored as memory failures, but participants were reminded to report memories from childhood. 
No participant had more than five responses that were not sufficiently remote in time (average = 
1.0). Memory failures occurred at approximately the same incidence (6.2% for promotion goal 
cues and 14% for control cues) as in previous studies (e.g., Strauman, 1992). After the 
posttreatment assessment, each participant was asked whether she or he had any guesses about 
study hypotheses. No participant identified her or his promotion goals as the purpose of the 
memory task. 
Failure in promotion goal pursuit reliably predicts level of dysphoric affect following priming of 
promotion goals ( Strauman, 1989, 1992). We used the sadness/depression score from the 
Linguistic Inquiry and Word Count (LIWC) computerized text analysis program ( Pennebaker, 
Francis, & Booth, 2001; Pennebaker & King, 1999) to measure the dysphoric content of each 
memory as an index of affective responses to promotion goal priming. 
Treatment adherence 
To assess adherence, we constructed a rating scale that was based on the Collaborative Study 
Psychotherapy Rating Scale (CSPRS; Evans, Piasecki, Kriss, & Hollon, 1984). SST items were 
generated from the SST manual ( Strauman et al., 2001). The scale contained 69 items across 
four subscales: Session Quality (14 items from the CSPRS; α = .84), assessing nonspecific 
aspects (e.g., rapport, bond); Common Features (21 items; α = .72), assessing aspects of therapy 
shared by SST and CT (e.g., agenda setting, scheduling activities, assigning homework, all 
drawn from the CSPRS); SST (19 items; α = .87); and CT (15 items from the CSPRS; α = .90). 
Sixty-three sessions were rated, including at least one tape from each participant and at least one 
tape from each therapist–treatment modality combination. Two postdoctoral fellows and one 4th-
year psychiatry resident were trained to serve as raters. To assess interrater reliability, we 
calculated intraclass correlation coefficients (ICCs; Shrout & Fleiss, 1979) between ratings 
obtained from two of the three possible raters on 22 tapes (selected at random from 22 different 
patients). Three of the four subscales showed acceptable interrater reliability (Common Features 
= .76, SST = .66, CT = .93, all p < .001), but the ICC for the Session Quality subscale was not 
significantly different from 0. The lack of agreement on this scale likely resulted from the 
difficulty of operationalizing those more qualitative constructs for reliable rating of therapist–
patient interactions ( Hill, O'Grady, & Elkin, 1992). As a result, the Session Quality subscale was 
not used in adherence analyses. 
Results 
Patient Characteristics 
The average age of the completers was 39.4 years ( SD = 14.2; range 19–72 years). Most were 
White (92.5%) and female (75%), and almost all reported prior treatment for depression. Table 1 
summarizes patient characteristics by treatment condition. The only statistically significant 
difference observed was that the SST condition had more patients with a comorbid anxiety 
disorder than the CT condition (38% vs. 11%, p < .05). However, the presence or absence of a 
comorbid anxiety was not predictive of change from pretreatment to posttreatment on the HRSD 
(β = .06, p > .5) or BDI (β = −.07, p > .40).  
Table 1. Patient Characteristics for Completers by Treatment Condition 
Characteristic SST(N=21) CT(N=18) Statistic p 
 M SD M SD  
Age 37.2  13.3  40.1  16.3  t(37) = -
0.67  
p > .50 
 No. % No. %  
Female  18  85.7  11  61.1  x2(1) = 
3.37 
p< .10 
Ethnicity   Fisher’s exact test p 
>.50 
White  19  90.4  17  94.4  
Latino/Latina  1  4.8  1  5.6  
Other  1  4.8  0  0.0  
Marital status   Fisher’s exact test p 
>.30 
Single, never 
married  
7  33.3  3  16.7  
Married/cohabitating  10  47.7  11  61.1  
Widowed  0  0.0  1  5.6  
Separated/divorced 4  19.0  3  16.7  
Educational level   Fisher’s exact test p 
>.50 
Some high school  1  4.8  0  0.0  
High school degree  7  33.3  6  33.3  
College degree  9  42.9  8  44.4  
Graduate or 
professional degree  
4  19.0  4  22.2  
Mood disorder 
diagnosis 
  x2(3) = 
0.61  
p >.50 
Major depressive 
disorder  
9  42.9  6  33.3  
Dysthymic disorder  4  19.0  4  22.2  
Both major 
depressive & 
dysthymic disorders  
5  23.8  5  27.8  
Other  3  14.3  3  16.7  
Anxiety disorder 
diagnosis  
8  38.1  2  11.1  x2(1) = 
4.24  
p <  .05 
Axis II diagnosis  14 12 12 66.7 x2(1) = 
0.00 
p  >.50 
Prior depression  18 85.7 16 88.9 x2(1) = 
0.05 
p  >.50 
Prior antidepressant 
medication  
9  42.9  11  61.1  x2(1) = 
1.54  
p >.20 
Prior psychotherapy  17  81.0  15  83.3  x2(1)  
0.02  
p  >.50 
Note. SST = self-system therapy; CT = cognitive therapy. 
Treatment Characteristics 
Quantity and adherence 
SST completers received more sessions ( M = 21.7) than CT completers ( M = 19.6), but the 
difference was not statistically significant, t(37) = 1.26, p > .25, and the number of sessions did 
not predict change from pretreatment to posttreatment on the HRSD (β = −.08, p > .4) or BDI (β 
= .04, p > .5). We compared the mean scores for the three adherence subscales with acceptable 
reliability within the two treatment conditions. Because some patients were included more than 
once within the subset of rated tapes, a mixed-model analysis of variance was used to isolate 
treatment effects. CT and SST did not differ on the Common Features subscale—CT M = 3.09, 
SST M = 2.98, F(1, 50) = 0.74, p >.5—indicating comparable agenda-setting, homework 
assignments, and other common elements. The SST sessions contained significantly more SST-
specific content than the CT sessions, CT M = 1.15, SST M = 1.99, F(1, 50) = 8.42, p < .001, 
whereas the CT sessions contained significantly more CT-specific content than the SST sessions, 
CT M = 2.68, SSTM = 1.49, F(1, 50) = −9.93, p < .001. 
Overall treatment efficacy 
Table 2 presents unadjusted pretreatment and posttreatment mean HRSD and BDI scores by 
treatment condition, as well as adjusted posttreatment means, for both intent-to-treat and 
completer analyses. Because the analyses yielded similar findings, we focus here on the 
completer analyses. We conducted a hierarchical regression analysis with the posttreatment 
HRSD score as the criterion variable and the pretreatment HRSD score as well as treatment 
condition (SST, CT) as predictors. The main effect of treatment condition was not statistically 
significant, F(1, 36) = 1.41, p > .2. Both treatments were associated with a substantial decrease 
in depressive symptoms (Cohen's d = 1.74 combining across treatments, 95% confidence interval 
[CI] = 1.21, 2.28). For SST, the mean HRSD scores were 19.4 at pretreatment and 6.5 at 
posttreatment (Cohen's d = 1.71, 95% CI = 1.00, 2.42); for CT, the mean HRSD scores were 20.7 
at pretreatment and 7.7 at posttreatment (Cohen's d = 1.87, 95% CI = 1.16, 2.70). In a similar 
hierarchical regression analysis with posttreatment BDI scores as the criterion variable, the main 
effect of treatment condition likewise was not statistically significant, F(1, 36) = 1.56, p > .2, 
Cohen's d = 1.68 combining across the two treatments, 95% CI = 1.15, 2.19. For SST, the mean 
BDI scores were 24.7 at pretreatment and 9.5 at posttreatment (Cohen's d = 1.75, 95% CI = 1.03, 
2.48); for CT, the mean BDI scores were 24.6 at pretreatment and 10.7 at posttreatment 
(Cohen's d = 1.65, 95% CI = 1.12, 2.19). These findings (both HRSD and BDI) were not affected 
by inclusion of number of therapy sessions or comorbid anxiety disorders as additional 
predictors.  
 
Table 2. Means and Standard Deviations of Pretreatment and Posttreatment Depression Scores 
by Treatment Condition 
 Intent-to-treat analysis 
 CT (N = 21) SST (N =24) 
 Pretreatment  Posttreatment Adjusted 
Posttreatment  
Pretreatment  Posttreatment Adjusted 
Posttreatment 
Meas
ure 
M  SD  M  SD  M  SD  M  SD  M  SD  M  SD 
HRS
D  
19.2  4.8  9.8  6.7  8.9  5.9  18.8  4.2  8.9  4.9  8.1  5.8 
BDI  24.0  5.9  12.8  8.9  12.0  9.1  24.6  4.8  10.2  6.9  10.0  6.6 
 Completer analysis 
 CT (N = 18) SST (N = 21) 
 Pretreatment  Posttreatment  Adjusted 
Posttreatment  
Pretreatment  Posttreatment Adjusted 
Posttreatment 
Meas
ure 
M  SD  M  SD  M  SD  M  SD  M  SD  M  SD 
HRS
D  
20.7  4.9  7.7  6.6  8.0  6.1  19.4  4.3  6.5  5.5  6.9  5.9 
BDI  24.6  6.2  10.7  7.1  10.2  8.1  24.7  5.1  9.5  6.8  7.9  6.2 
Note. CT = cognitive therapy; SST = self-system therapy; Adjusted posttreatment M and SD = 
adjusted for pretreatment mean; HRSD = Hamilton Rating Scale for Depression (Hamilton, 
1960; Williams, 1988); BDI = Beck Depression Inventory (Beck, Ward, Mendelson, Mock, & 
Erbaugh, 1961). 
Clinically significant change 
We determined which patients had a decrease greater than 50% on both HRSD and BDI scores ( 
Hageman & Arrindell, 1999). For SST, 12 of 21 (57.2%) patients met these criteria; for CT, 9 of 
18 (50.0%) did so. This difference was not statistically significant by Fisher's exact test ( p > .5). 
Using the criterion for recovery from depression of the Treatment of Depression Collaborative 
Research Program ( Elkin, 1994), we also determined which patients had a posttreatment score 
of 6 or less on the BDI. According to this criterion, 9 (47.6%) of the SST patients and 6 (33.3%) 
of the CT patients had recovered. This difference was not statistically significant by Fisher's 
exact test ( p > .15). 
Differential efficacy as a function of promotion history 
To determine whether SST was more efficacious for patients with low scores on the Promotion 
History subscale of the RFQ, we conducted a hierarchical regression analysis with posttreatment 
HRSD score as the criterion variable. As we did in the section above, because the intent-to-treat 
and completer analyses yielded similar findings, we focus on the latter. In the first step, entering 
the pretreatment HRSD score accounted for 25% of the variance ( p < .001, β = .50). In the 
second step, treatment condition was entered but did not account for a significant increment in 
variance ( ΔR2 = .04, p > .20). In the final step, we entered the RFQ Promotion History subscale 
and its interaction with treatment condition. This step accounted for a significant increment in 
variance ( ΔR2 = .10, p < .05); promotion history was not predictive of HRSD score ( p > .25), 
but the Promotion History × Treatment Condition interaction was ( sR2 = .09, p < .05). To assess 
discriminant validity, we repeated this analysis using the other RFQ subscales (Prevention 
History, Promotion Pride, and Prevention Pride); no significant main effect or interaction with 
treatment condition was observed for those subscales (all sR2s < .03). We then probed the 
significant interaction by testing for differences in posttreatment HRSD as a function of 
treatment and promotion history. Following the method used by Cohen, Cohen, West, and Aiken 
(2003), we computed posttreatment HRSD scores for low (−1 SD), moderate (mean), and high 
(+1 SD) levels of promotion history within each treatment condition; Figure 2 depicts estimated 
HRSD scores by treatment condition and level of promotion history. Low-promotion-history 
patients receiving SST had significantly greater reduction in HRSD scores (from 20.2 to 4.8) 
than did low-promotion-history patients receiving CT (from 21.2 to 12.1), F(1, 34) = 5.59, p < 
.05. No other pair of scores differed significantly from each other, indicating that the difference 
between treatments was limited to the lower end of the range of RFQ promotion history scores.  
 
 
Figure 2. Predicted posttreatment Hamilton Rating Scale for Depression (HRSD; Hamilton, 
1960; Williams, 1988) scores by treatment condition and level of promotion history (1 standard 
deviation below the mean, mean, and 1 standard deviation above the mean), adjusted for 
pretreatment HRSD. Means and standard errors are presented for each treatment–promotion 
history combination. SST = self-system therapy, CT = cognitive therapy 
We conducted a similar hierarchical regression analysis with the posttreatment BDI score as the 
criterion variable. In the first step, we entered the pretreatment BDI score, which accounted for 
13% of the variance (β = .36, p < .01). In the second step, we entered treatment condition, which 
did not account for a significant increment in variance ( ΔR2 = .03, p > .25). In the final step, we 
entered the RFQ Promotion History subscale and its interaction with treatment condition. This 
step accounted for a significant increment in variance ( ΔR2 = .09, p < .05). The RFQ Promotion 
History subscale did not predict BDI scores ( p > .25), whereas the Promotion History × 
Treatment Condition interaction approached statistical significance ( sR2 = .07, p < .10). Probing 
the interaction revealed the same pattern of slopes, with greatest difference observed between 
low-promotion-history patients receiving SST and those receiving CT. A simple slopes 
comparison test indicated that the low-promotion-history patients who received SST had a 
significantly greater reduction in BDI than the low-promotion-history patients who received 
CT, t(35) = 2.42, p < .05. Repeating this analysis using the other three RFQ subscales, we found 
no significant main effect or interaction with treatment (all sR2s < .03). 
Effects of treatment on dysphoric responses to promotion goal priming 
To test the differential mechanism of action hypothesis (that SST would lead to greater reduction 
in dysphoric responses to priming of promotion goals than CT), we conducted a repeated 
measures analysis of variance using the LIWC sadness/depression score as the dependent 
measure, time (pretreatment, posttreatment) and cue type (promotion goal, yoked-control) as 
within-subject variables, and treatment condition (SST, CT) as a between-subjects variable. The 
analysis revealed a significant main effect of time, F(1, 35) = 12.04, p < .001, as well as a 
significant Time × Treatment Condition × Cue Type interaction, F(1, 35) = 4.49, p < .05. There 
was a decrease in dysphoric memory content primed by promotion goals from pre- to 
posttreatment, compared with that primed by yoked control; however, that trend was qualified by 
the significant three-way interaction. Specifically, SST led to a significant decrease in dysphoric 
content following promotion goal priming (pretreatment M = 1.0; posttreatment M = 0.4), F(1, 
36) = 5.58, p < .05, whereas CT did not (pretreatment M = 0.8; posttreatment M = 0.7), F(1, 36) 
= 0.95, p > .5; there were no significant changes in dysphoric content following yoked-control 
priming. As a further test, we examined the association between symptom reduction and change 
in affective response to promotion priming using simple change scores and calculating 
correlations within each treatment condition. For SST, the correlation between symptom and 
dysphoric affect change scores was statistically significant ( r = .35, p < .05); for CT, the 
correlation was not statistically significant ( r = .11, p > .25). However, the two correlations were 
not significantly different by Pearson's z transformation test ( p > .20). 
Discussion 
SST is a new therapy based on a model of depression as a disorder of motivation and goal 
pursuit. Following previous research ( Strauman et al., 2001), we hypothesized that SST would 
be differentially beneficial for depressed patients who were unable to pursue promotion goals 
effectively. In this randomized clinical trial, although both CT and SST were efficacious overall, 
SST was more efficacious for individuals whose self-reported socialization history lacked an 
emphasis on promotion and who therefore, according to regulatory focus theory, would be less 
able to pursue promotion goals effectively. SST also led to greater change in dysphoric responses 
to promotion goal priming, suggesting that the two treatments may have different mechanisms of 
action. We believe these findings illustrate the potential of a translational approach to the 
development and selection of treatments for depression. 
The differential efficacy hypothesis tested in this study predicted that a specific individual 
difference variable, promotion history, would moderate treatment outcome ( Kraemer, Wilson, 
Fairburn, & Agras, 2002). The moderation effect represented an average posttreatment difference 
of approximately 6 points on the HRSD—a substantial effect both statistically and clinically. 
Although we did not assess patients' promotion goals during treatment (to avoid possible 
contamination of the therapy process), the findings suggest that SST helps to reduce negative 
affect associated with the individual's unmet promotion goals, which in turn would enhance an 
individual's ability to pursue such goals ( Vieth et al., 2003). The other three RFQ subscales were 
not predictive of outcome (either as main effects or interacting with treatment condition), a 
pattern that provided support for the discriminant validity of our predictions. 
Why might individual differences in promotion history be predictive of response to SST versus 
CT? The RFQ Promotion History subscale is intended to measure the extent to which an 
individual was socialized during childhood toward construing life events in terms of making 
good things happen ( Higgins, 1989, 1997; Manian, Papadakis, Strauman, & Essex, in press). As 
such, the score on the Promotion History subscale should predict one's ability to pursue 
promotion goals effectively. Promotion history is only minimally correlated with extraversion, 
suggesting that it is not a measure of individual differences in behavioral activation system 
strength ( Merrill, Dolcos, et al., 2006). Promotion history is also predictive of intensity of left 
prefrontal cortical activation following promotion goal priming in healthy controls ( Merrill, 
Dolcos, et al., 2006), and a similar measure of orientation to promotion goals was predictive of 
left frontal resting EEG activity ( Amodio, Shah, Siegelman, Brazy, & Harmon-Jones, 2004). 
Extrapolating from those studies, we proposed that depressed individuals reporting low levels of 
promotion-focused socialization during childhood may not have learned how to make good 
things happen and so would be vulnerable to depression via a pathway involving chronic failure 
to make progress toward promotion goals ( Strauman, 2002). The emphasis in SST on the 
distinction between promotion and prevention, each of which involves specific strategies for goal 
pursuit, may have provided a perspective and skill set that allowed these individuals to initiate a 
self-reinforcing process of pursuing promotion goals. 
In contrast, prevention history represents the extent to which an individual was socialized toward 
construing life events in terms of keeping bad things from happening and was not predictive of 
outcome. The Promotion Pride and Prevention Pride subscales, which in nonpsychiatric samples 
are moderately correlated with depressive symptoms, likewise were not predictive of response to 
either CT or SST. We had not expected the Promotion Pride and Prevention Pride subscales to be 
predictive of outcome because they represent the individual's current assessment of her or his 
overall success in goal pursuit and that judgment covaries with extent of depressive symptoms. 
The present findings are consistent with research on the motivational and affective consequences 
of individual differences in regulatory focus, as well as with models of depression emphasizing 
motivational deficits in response to approach goals (e.g., Mayberg, 2003; Watson et al., 1999). 
Replication with other measures of promotion goal activation and pursuit could shed additional 
light on how, and for whom, SST might be effective. Furthermore, a randomized clinical trial 
making a priori predictions regarding response to SST would subject the differential efficacy and 
mechanism of action hypotheses to “grave danger of refutation” ( Meehl, 1978, p. 806). 
To conclude that SST was more efficacious for a subset of patients, we must show that CT was 
delivered with sufficient fidelity. In our adherence data, CT and SST did not differ on the 
Common Features subscale, whereas each was rated significantly higher on its corresponding 
subscale. That is, CT and SST were rated as equivalent with regard to shared features such as 
agenda setting and homework but differed with regard to treatment-specific interventions. The 
means for the SST and CT conditions on the Common Features subscale, as well as on the mean 
CT subscale score for the CT condition, were equivalent to those reported in prior studies using 
the CSPRS (e.g., Hill et al., 1992). 
The CT in this study also can be assessed via benchmarks ( Merrill, Tolbert, & Wade, 2003). Our 
CT condition led to an average 63% reduction in HRSD scores (from 20.7 to 7.7). DeRubeis et 
al., (2005) reported estimated average reductions in HRSD scores for a 16-week course of CT of 
approximately 58% at one site (from approximately 24 to 10) and approximately 48% at another 
(from approximately 23 to 12). Similarly, Blackburn and Moore (1997) reported an average 
reduction in HRSD scores of 44% for a 16-session course of CT (from 19.2 to 10.7). Although 
our patients were less depressed on average than in those in the studies by Blackburn and Moore 
(1997) and DeRubeis et al., (2005), the degree of improvement in patients in our CT condition 
was comparable (although our CT patients received on average 18.2 sessions, whereas the two 
studies cited as benchmarks used 16-week and 16-session protocols, respectively). 
We also compared our findings with findings for the CT condition reported by Strauman et al. 
(2001, Study 2). In that trial, depressed patients receiving CT manifested an average 57% 
reduction in HRSD scores (from 21.9 to 9.6) during a course of treatment with the number of 
sessions comparable to the number of sessions in the present study (16.9 sessions)—an average 
outcome consistent with the CT condition in the current study. For the subset of patients with 
chronic failure to attain promotion goals who received CT, Strauman et al. (2001) reported an 
average 42% reduction in HRSD scores (from 22.0 to 12.8), compared with an estimated average 
43% reduction in HRSD scores (from 21.7 to 12.4, according to regression analysis) for similar 
patients in the present trial. Thus, there are several indirect sources of evidence suggesting that 
CT was delivered competently in the present study. 
Although this study indicated that a subset of depressed patients benefited differentially from 
SST and that SST had a greater impact than CT on affective responses to promotion goals, other 
treatment approaches might be effective for such patients. We did not attempt to modify or 
lengthen CT or to train therapists providing CT to focus their efforts on identifying problematic 
goals and goal pursuit strategies. CT has been shown in numerous studies to be both efficacious 
and flexible, so it provided a strong comparison condition. It will be important to explore 
whether CT (or other treatments) could be modified to help patients with poor promotion goal 
pursuit attain recovery. Follow-up analyses will also help to clarify questions of the utility of 
SST versus CT for relapse prevention within subsets of depressed patients. 
One advantage of a translational approach to treatment development is the possibility of 
identifying theory-based targets for change ( Strauman & Merrill, 2004). In this trial, almost all 
patients' courses of treatment were ended when the set of tasks or milestones stipulated within 
that treatment model had been addressed. However, other criteria might have been used 
(including a fixed number of sessions per patient, which we chose not to do in the absence of 
data regarding the average number of sessions in a course of treatment with SST; see below). It 
may be possible to develop a “treat-to-criterion” strategy for SST, in which treatment length and 
session content are guided by the patient's progress on measures of promotion goal pursuit. 
Another advantage of translational research is that findings obtained in studies applying theory to 
intervention can be relevant to the underlying theory itself and to models of how treatments 
work. For example, we found no difference between SST and CT as a function of patients' 
ratings of their overall success or failure in goal pursuit (the RFQ Promotion Pride and 
Prevention Pride subscales). This may indicate that both treatments address self-evaluation 
processes, whereas SST may be better suited for patients with relative deficits in goal pursuit. 
Because this was the first comparative trial of SST, we elected not to fix the length of treatment, 
introducing a naturalistic element within a controlled design. This decision allowed us to gather 
data regarding characteristics of SST, but it also limited the conclusions that could be drawn. In 
particular, although treatment length was not correlated with outcome, the possibility that 
therapists inadvertently ended treatment differentially according to treatment condition or 
promotion history cannot be ruled out entirely. Replication studies should ensure that treatment 
conditions being compared are of identical duration. The present findings suggest that it should 
be possible to deliver SST, like CT, within a structured 16-week course of treatment. 
The possibility of allegiance and therapist effects also must be considered because the study was 
conducted by SST's developers. Although the data suggest that CT and SST were delivered with 
appropriate adherence and we found no evidence for substantial allegiance effects, replication by 
unaffiliated investigators is still required. Also, although seven of the nine therapists provided 
both treatments, one provided only CT and another only SST; in addition, therapists saw 
different numbers of patients in each treatment condition. As a supplementary analysis, we 
conducted a mixed-model repeated measures analysis of variance with pretreatment and 
posttreatment HRSD scores as dependent variables, treatment condition and promotion history as 
fixed effects, and therapist as a random effect. This analysis revealed no statistically significant 
main effects or interactions involving the therapist random effect (all p > .20). However, our 
sample size provided sufficient power only to detect a large effect size in this case (Cohen's d = 
0.9), so more subtle therapist effects may have escaped detection. 
There are a number of other limitations of the study that should be acknowledged. First, the 
inclusion of multiple affective disorder diagnostic categories (specifically, 14 of the 40 patients 
did not meet all criteria for major depressive disorder) resulted in a sample that was somewhat 
less depressed than those in other clinical trials involving CT. Second, although efforts were 
made to ensure the equivalence of training and supervision across the two treatments, the fact 
that therapists all had prior training and experience in CT but learned SST specifically for this 
study implies that there were at least minimal differences between the two conditions in terms of 
training experiences. Third, only CT and SST were included; a larger study including additional 
modalities (psychological and pharmacologic) would provide important data regarding the 
generalizability of the differential outcome and mechanism of action findings across available 
treatments. 
Finally, the mechanisms of action by which SST and CT are hypothesized to lead to changes in 
psychological processes deserve further attention. Our analysis of treatment effects on dysphoric 
responses to promotion goal priming was a first step in elucidating one possible modality-
specific mechanism, but more fine-grained analyses would be helpful. For example, it would be 
useful to determine whether the promotion and prevention goals identified by each patient before 
treatment became focal topics during treatment and whether the extent to which such goals were 
topics of discussion could be predictive of outcome in either condition. Likewise, it would be 
important to consider whether additional techniques might be included in SST to enhance its 
impact on self-regulation. Elucidating the shared and unique mechanisms of action of CT and 
SST could enhance the ability of therapist–patient dyads to maximize outcome. Nonetheless, we 
are encouraged that a self-regulation perspective on depression may be of value for treatment and 
that a translational approach to treatment development and matching may indeed be useful. 
Footnotes 
1 We also conducted hierarchical regression analyses predicting posttreatment HRSD and BDI 
scores that included number of therapy sessions and the presence or absence of a comorbid 
anxiety disorder as covariates. Neither covariate influenced the overall pattern or statistical 
significance of the findings reported above. 
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